Clinton D. Protack, MD, Andrew M. Bakken, MD, Jiaqiong Xu, PhD, Wael A

Slides:

Advertisements

Similar presentations

The impact of renal insufficiency on the outcome of carotid surgery is influenced by the definition used Benjamin Kretz, MD, Nicolas Abello, PhD, Roger.

Advertisements

Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease Joseph P. Archie, PhD, MD Journal of Vascular.

Intermediate-term outcome of carotid endarterectomy with bovine pericardial patch closure compared with Dacron patch and primary closure Karen J. Ho,

Carotid stenting versus endarterectomy in patients undergoing reintervention after prior carotid endarterectomy Margriet Fokkema, MD, Gert Jan de Borst,

Susanna L. Matsen, MD, Bruce A. Perler, MD, MBA, David C

Anesthetic type and risk of myocardial infarction after carotid endarterectomy in the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST)

Comparison of carotid endarterectomy and stenting in real world practice using a regional quality improvement registry Brian W. Nolan, MD, MS, Randall.

Hyperperfusion syndrome after carotid revascularization

The Cardiovascular Fellows Bootcamp

Allan B. Dunlap, MD, Gregory S. Kosmorsky, DO, Vikram S. Kashyap, MD

Long-term survival and stroke-free survival after eversion carotid endarterectomy for asymptomatic severe carotid stenosis Enzo Ballotta, MD, Giorgio.

Durability of eversion carotid endarterectomy

Early and long-term results of carotid endarterectomy in diabetic patients Walter Dorigo, MD, Raffaele Pulli, MD, Giovanni Pratesi, MD, Aaron Fargion,

Eight-year institutional review of carotid artery stenting

Impact of diabetes mellitus on outcomes of superficial femoral artery endoluminal interventions Andrew M. Bakken, MD, Eugene Palchik, MD, Joseph P. Hart,

Mark G. Davies, MD, PhD, MBA, Wael E. Saad, MD, Jean X

Mark G. Davies, MD, PhD, Wael E. Saad, MD, Eric K. Peden, MD, Imran T

Using distal revascularization with interval ligation as the primary treatment of hand ischemia after dialysis access creation Rahim Aimaq, MD, Steven.

Lowell S. Kabnick, MD Journal of Vascular Surgery

Margriet Fokkema, MD, Rodney P. Bensley, MD, Ruby C. Lo, MD, Allan D

Stephen F. Stanziale, MD, Luke K. Marone, MD, Tamer N

Mesenteric stenting for chronic mesenteric ischemia

Philip P. Goodney, MD, Donald S. Likosky, PhD, Jack L. Cronenwett, MD

The Cardiovascular Fellows Bootcamp

Intermediate-term outcome of carotid endarterectomy with bovine pericardial patch closure compared with Dacron patch and primary closure Karen J. Ho,

Impact of diabetes on carotid artery revascularization

Thrombolysis for lower extremity bypass graft occlusion

Christopher J. Smolock, MD, Javier E

Clinical efficacy of concomitant tibial interventions associated with superficial femoral artery interventions in critical limb ischemia Christopher.

Susanna L. Matsen, MD, David C. Chang, PhD, MPH, MBA, Bruce A

Impact of statin therapy on patients with coronary heart disease and aortic aneurysm or dissection Junichi Tazaki, MD, Takeshi Morimoto, MD, PhD, Ryuzo.

Thomas S. Huber, MD, PhD, Michael P. Brown, DO, James M. Seeger, MD, W

Prospective study of carotid endarterectomy with modified polytetrafluoroethylene (ACUSEAL) patching: Early and late results Ali F. AbuRahma, MD, Patrick.

Long-term results of 442 consecutive, standardized carotid endarterectomy procedures in standard-risk and high-risk patients D. Preston Flanigan, MD,

Diabetes is not a predictor of outcome for carotid revascularization with stenting as it may be for carotid endarterectomy Gianbattista Parlani, MD,

Current efficacy of open and endovascular interventions for advanced superficial femoral artery occlusive disease Christopher J. Smolock, MD, Javier.

Carotid endarterectomy in octogenarians: Comparison with patient characteristics and outcomes in younger patients Joseph R. Schneider, MD, PhD, Julie.

Joseph R. Schneider, MD, PhD, Julie S. Droste, BSN, RN, John F

Early and long-term outcomes of carotid endarterectomy in the very elderly: An 18-year single-center study Enzo Ballotta, MD, Giuseppe Da Giau, MD, Mario.

Karthikeshwar Kasirajan, MD, Mark D. Morasch, MD, Michel S

Long-term outcomes of primary angioplasty and primary stenting of central venous stenosis in hemodialysis patients Andrew M. Bakken, MD, Clinton D. Protack,

Outcomes of symptomatic abdominal aortic aneurysm repair

Todd R. Vogel, MD, MPH, Robin L. Kruse, PhD

Endarterectomy versus stenting in patients with prior ipsilateral carotid artery stenting Isibor J. Arhuidese, MD, MPH, Besma Nejim, MD, MPH, Susruth.

Ali F. AbuRahma, MD, Patrick A

Soma Brahmanandam, MD, MPH, Eric L. Ding, ScD, Michael S

Wei Zhou, MD, Peter H. Lin, MD, Ruth L. Bush, MD, Eric K

Impact of runoff on superficial femoral artery endoluminal interventions for rest pain and tissue loss Mark G. Davies, MD, PhD, Wael E. Saad, MD, Eric.

Radiation arteritis: A contraindication to carotid stenting?

Predictors of 30-day postoperative stroke or death after carotid endarterectomy using the 2012 carotid endarterectomy-targeted American College of Surgeons.

Proposed duplex velocity criteria for carotid restenosis following carotid endarterectomy with patch closure Ali F. AbuRahma, MD, Patrick Stone, MD,

Alert for increased long-term follow-up after carotid artery stenting: Results of a prospective, randomized, single-center trial of carotid artery stenting.

The influence of metabolic syndrome on hemodialysis access patency

Secondary interventions following endovascular abdominal aortic aneurysm repair using current endografts. A EUROSTAR report Roel Hobo, MSc, Jacob Buth,

Long-term prognostic factors after thrombolysis for lower limb ischemia Monica Kuoppala, MD, Sofia Franzén, MD, Bengt Lindblad, MD, PhD, Stefan Acosta,

M. Hassan Murad, MD, MPH, David N. Flynn, BS, Mohamed B

A personal experience with coronary artery bypass grafting, carotid patching, and other factors influencing the outcome of carotid endarterectomy Norman.

Should patient age be a consideration in carotid endarterectomy?

Selective external endarterectomy in patients with ipsilateral symptomatic internal carotid artery occlusion Margriet Fokkema, MD, Boudewijn L. Reichmann,

A comparative analysis of the outcomes of carotid stenting and carotid endarterectomy in women Paola De Rango, MD, Gianbattista Parlani, MD, Valeria.

Theodore H. Yuo, MD, MS, Joseph Sidaoui, MD, Luke K

Emily L. Spangler, MD, MS, Philip P

J. David Neel, MD, Robin L. Kruse, PhD, Viktor Y

Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease Joseph P. Archie, PhD, MD Journal of Vascular.

The effect of postoperative stroke and myocardial infarction on long-term survival after carotid revascularization Jessica P. Simons, MD, MPH, Philip.

Stroke and death after carotid endarterectomy and carotid artery stenting with and without high risk criteria Kristina A. Giles, MD, Allen D. Hamdan,

Prospective randomized study evaluating an absorbable cyanoacrylate for use in vascular reconstructions Alan B. Lumsden, MD, Eugene R. Heyman, PhD Journal.

Scott M. Surowiec, MD, Mark G. Davies, MD, PhD, Shirley W

Carotid artery stenting has increased rates of postprocedure stroke, death, and resource utilization than does carotid endarterectomy in the United States,

Carotid artery stenting outcomes are equivalent to carotid endarterectomy outcomes for patients with post-carotid endarterectomy stenosis Ali F. AbuRahma,

Presentation transcript:

Metabolic syndrome: A predictor of adverse outcomes after carotid revascularization Clinton D. Protack, MD, Andrew M. Bakken, MD, Jiaqiong Xu, PhD, Wael A. Saad, MD, Alan B. Lumsden, MD, Mark G. Davies, MD, PhD, MBA Journal of Vascular Surgery Volume 49, Issue 5, Pages 1172-1180.e1 (May 2009) DOI: 10.1016/j.jvs.2008.12.011 Copyright © 2009 Society for Vascular Surgery Terms and Conditions

Fig 1 Freedom from major adverse events (MAE). Two hundred five (32%) No-MetS and 116 (41%) MetS patients experienced a MAE (stroke, MI, or death) during follow-up, (P < .05). The 3-year freedom from MAE rates were 42% and 32% for MetS and No-MetS, respectively. Error bars are omitted for clarity. Standard error did not exceed 10% at all time intervals that were analyzed. The number of patients at risk at each time interval is shown below the Fig. Journal of Vascular Surgery 2009 49, 1172-1180.e1DOI: (10.1016/j.jvs.2008.12.011) Copyright © 2009 Society for Vascular Surgery Terms and Conditions

Fig 2 Freedom from stroke. Twenty-seven (4%) No-MetS and 23 (8%) No-MetS patients experienced a stroke during follow-up, (P < .05). The 3-year freedom from stroke rates were 93% and 96% for MetS and No-MetS, respectively. Error bars are omitted for clarity. Standard error did not exceed 10% at all time intervals that were analyzed. The number of patients at risk at each time interval is shown below the Fig. Journal of Vascular Surgery 2009 49, 1172-1180.e1DOI: (10.1016/j.jvs.2008.12.011) Copyright © 2009 Society for Vascular Surgery Terms and Conditions

Fig 3 Freedom from myocardial infarction (MI). Thirty-four (5%) No-MetS and 55 (19%) MetS patients experienced an MI during follow-up, (P < .05). The 3-year freedom from MI rates were 88% and 96% for MetS and No-MetS, respectively. Error bars are omitted for clarity. Standard error did not exceed 10% at all time intervals that were analyzed. The number of patients at risk at each time interval is shown below the fig. Journal of Vascular Surgery 2009 49, 1172-1180.e1DOI: (10.1016/j.jvs.2008.12.011) Copyright © 2009 Society for Vascular Surgery Terms and Conditions

Fig 4 Survival. Four hundred sixty-one (72%) No-MetS and 201 (71%) MetS patients survived during follow-up, (P = NS). the 3-year survival rates were 84% and 87% for MetS and No-MetS, respectively. Error bars are omitted for clarity. Standard error did not exceed 10% at all time intervals that were analyzed. The number of patients at risk at each time interval is shown below the Fig. Journal of Vascular Surgery 2009 49, 1172-1180.e1DOI: (10.1016/j.jvs.2008.12.011) Copyright © 2009 Society for Vascular Surgery Terms and Conditions

Fig 5 Freedom from restenosis. The 3-year freedom from restenosis rates were 84% and 70% for patients undergoing CEA and CAS, respectively. Error bars are omitted for clarity. Standard error did not exceed 10% at all time intervals that were analyzed. The number of patients at risk at each time interval is shown below the Fig. Journal of Vascular Surgery 2009 49, 1172-1180.e1DOI: (10.1016/j.jvs.2008.12.011) Copyright © 2009 Society for Vascular Surgery Terms and Conditions